Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2 × Lymphopenia × Interleukin-7 × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Lymphopenia 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Lymphoma, B-Cell 1 Carcinoma, Transitional Cell 1 COVID-19 1 Breast Neoplasms 1

Interventions

Interleukin-7 2 Thymalfasin 1 Sodium Chloride 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04426201 2024-04-11

ILIAD-7-US-O

Revimmune

Phase 2 Terminated

COVID-19, Lymphopenia

NCT01368107 2015-02-09

Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients

Centre Leon Berard

Phase 2 Completed

Breast Neoplasms, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡